BioVie Inc.
Formulations of Terlipressin

Last updated:

Abstract:

The disclosure provides pharmaceutical compositions comprising terlipressin having increased concentration with long term storage stability.

Status:
Application
Type:

Utility

Filling date:

18 Mar 2022

Issue date:

30 Jun 2022